Company Sends Letter to Retain Hormone Sales

Moving quickly to try to prevent women from stopping their hormone replacement treatments because of fear of breast cancer, the Wyeth company has sent 500,000 letters to doctors and other health care providers urging them to consider when they talk to patients the ''critical role'' that one of its products, Prempro, has in relieving the symptoms of menopause.